Point72 Middle East FZE’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-54,592
Closed -$2.02M 584
2023
Q4
$2.02M Buy
54,592
+9,193
+20% +$346K 0.06% 391
2023
Q3
$1.73M Buy
45,399
+41,019
+937% +$1.68M 0.06% 391
2023
Q2
$158K Buy
+4,380
New +$149K ﹤0.01% 1120

Other funds holding HALO

Point72 Middle East FZE's HALO Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Halozyme (HALO) in Q1 2024, closing a stake of 54,592 shares — an estimated $2.02M sold.

Point72 Middle East FZE first reported a position in HALO in Q2 2023 and held it in 3 quarters. The position peaked at $2.02M in Q4 2023. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 54,592 Halozyme shares in Q1 2024, an estimated $2.02M.
  • Point72 Middle East FZE first reported a position in Halozyme in Q2 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's Halozyme position peaked at $2.02M in Q4 2023.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.